MackMitchellMDFACP, FAASLD
Gastroenterology • Dallas, TXHepatology & Liver Transplantation
VP for Medical Affairs UT Southwestern Professor Internal Medicine University Texas Southwestern Medical Center Dallas, TX
Dr. Mitchell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UT Harry Hines Blvd
Stop 5323
Dallas, TX 75390Phone+1 214-648-5036Fax+1 214-645-0078
Summary
- Dr. Mack Mitchell is a gastroenterologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 40 years. He specializes in hepatology & liver transplantation and is experienced in general gastroenterology, hepatology, alcoholic liver disease, transplant hepatology, and biliary tract disease.
Education & Training
Vanderbilt University Medical CenterFellowship, Gastroenterology, 1980 - 1982
Johns Hopkins UniversityFellowship, Gastroenterology, 1979 - 1980- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1979
- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
TX State Medical License 2011 - 2025
MD State Medical License 1979 - 2013
NC State Medical License 1996 - 2012
TN State Medical License 1980 - 1982- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- Efficacy Study of Anakinra, Pentoxifylline, and Zinc Compared to Methylprednisolone in Severe Acute Alcoholic Hepatitis Start of enrollment: 2013 Sep 01
- Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis Start of enrollment: 2013 Aug 01
- Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Start of enrollment: 2020 Jul 10
Publications & Presentations
PubMed
- 349 citationsStandard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaDavid W. Crabb, Ramon Bataller, Naga Chalasani, Patrick S. Kamath, Michael R. Lucey
Gastroenterology. 2016-04-01 - 92 citationsA phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopyMark T. Worthington, Laurie J. Antonik, D. Ronald Goldwater, James P. Lees, Karin Wilhelm-Ogunbiyi
Anesthesia and Analgesia. 2013-11-01 - 19 citationsDesign and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis.Srinivasan Dasarathy, Mack C. Mitchell, Bruce A. Barton, Craig J. McClain, Gyongyi Szabo
Contemporary Clinical Trials. 2020-07-31
Press Mentions
Amygdala Neurosciences Announces $5.6M Financing and Dr. Mack Mitchell's Expanded Role as CMONovember 18th, 2019
Alcohol Destroyed Their Livers. Now, They're Increasingly Getting New OnesJanuary 22nd, 2019
Southwestern Health Resources ACN Saves More Than $73M in Three YearsNovember 22nd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
